Treatment of acute lymphoblastic leukemia in adults
- 1 January 1985
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 3 (1) , 49-53
- https://doi.org/10.1002/hon.2900030107
Abstract
Thirty‐seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, l‐Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patients with initial leukocyte count below 20 000/mmc experienced a longer remission (median not reached) than patients with a leukocyte count above 20 000/mmc (median 10 months).Keywords
This publication has 8 references indexed in Scilit:
- High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphomaCancer Chemotherapy and Pharmacology, 1984
- Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols.Journal of Clinical Oncology, 1983
- Fatal Pulmonary Embolism and Antithrombin III Deficiency in Adult Lymphoblastic Leukaemia during L-Asparaginase TherapyActa Haematologica, 1983
- Effective multidrug, multimodality consolidation therapy of adult acute lymphocytic leukemia:A preliminary reportCancer, 1982
- Retrospective Analysis of Treatment of Acute Myeloblastic Leukemia in Patients More Than 55 Years OldActa Haematologica, 1982
- Improved survival from acute lymphoblastic leukemia in adolescents and adultsCancer, 1981
- Combination chemotherapy for acute lymphoblastic leukaemia in adults.BMJ, 1978